Why Teloryx exists
Peptide information online often collapses very different things into one confident claim: a result in cultured cells, a result in mice, an early human trial, an approved medicine, and a vial sold by an unknown supplier. Those are not equivalent.
Teloryx exists to show the boundary of the evidence. A completed review identifies the regulatory status, strength and type of evidence, important limitations, review date, and direct sources. A page that has not completed this process is visibly marked as pending.
What we publish
Teloryx publishes compound evidence reviews, a review-status index, and concentration-mathematics worksheets. Reviewed pages separate established human outcomes from investigational signals, animal findings, laboratory mechanisms, and unknowns.
Legacy dosage tables and procedural guides are not published while their sources and safety assumptions remain unverified. The calculator checks arithmetic only from values supplied by an authoritative label, registered study protocol, pharmacist, or qualified clinician; it does not create a dose or regimen.
How to read the site
Look first for the evidence panel at the top of an article. It shows a grade, the basis for that grade, the date reviewed, and the number of linked sources. If the panel says Review pending, treat the article as unverified background rather than a completed scientific review.
An approval applies to a specific product, formulation, indication, population, and route. It does not validate a research vial, compounded copy, different salt, blend, concentration, manufacturer, or off-label use.
Who we are—and are not
Teloryx is an editorial project, not a healthcare provider, pharmacy, laboratory, manufacturer, or peptide seller. Pages do not claim clinician review unless a named reviewer and relevant qualification appear on that page. We do not invent author credentials or use a generic medical title to imply oversight.
Nothing on Teloryx is personal medical advice or a recommendation to obtain, prepare, or administer a substance. For the complete grading method, source rules, correction process, and conflict policy, read the Editorial Policy.